Comparison of M-2 protocol with COP in patients with nodular lymphoma.

Abstract:

:58 consecutively referred, previously untreated patients with nodular lymphomas (stages III and IV) were treated with two different combination chemotherapy regimens-(cyclophosphamide, vincristine and prednisone (COP), and BCNU , cyclophosphamide, vincristine, melphalan and prednisone (M-2) - to compare remission induction and duration as well as survival. The two groups were comparable for age, stage IV and histology. The complete response for each combination was greater than 80%. Median duration of remission for the COP-treated patients is 18 months. Remission duration and survival are superior for M-2-treated patients. The difference in remission duration and survival advantage is statistically significant for the M-2 protocol compared with COP at 5 years (p less than 0.01).

journal_name

Oncology

journal_title

Oncology

authors

Case DC Jr

doi

10.1159/000225814

subject

Has Abstract

pub_date

1984-01-01 00:00:00

pages

159-63

issue

3

eissn

0030-2414

issn

1423-0232

journal_volume

41

pub_type

杂志文章

相关文献

ONCOLOGY文献大全
  • 17-beta-hydroxysteroid dehydrogenase in human breast and endometrial carcinoma. A new development in intracrinology.

    abstract::Intratumoral metabolism and synthesis of estrogens are considered to play very important roles in the pathogenesis and development of various sex steroid-dependent neoplasms including breast and endometrial carcinoma. 17 beta-Hydroxysteroid dehydrogenase (17 beta-HSD) isozymes catalyze the interconversion of estradiol...

    journal_title:Oncology

    pub_type: 杂志文章,评审

    doi:10.1159/000055281

    authors: Sasano H,Suzuki T,Takeyama J,Utsunomiya H,Ito K,Ariga N,Moriya T

    更新日期:2000-01-01 00:00:00

  • Phase II study of UFT plus leucovorin in colorectal cancer.

    abstract::The activity and toxicity of UFT (Tegafur and Uracil) in a 4:1 molar concentration, plus leucovorin (LV), were evaluated in the treatment of 45 patients with advanced, bidimensionally measurable metastatic colorectal carcinoma. Initially 350 and later 300 mg/m2/day, plus 150 mg LV, as administered in divided doses eve...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章

    doi:10.1159/000227741

    authors: Pazdur R

    更新日期:1997-01-01 00:00:00

  • Self-Reported Adherence to Trifluridine and Tipiracil Hydrochloride for Metastatic Colorectal Cancer: A Retrospective Cohort Study.

    abstract:BACKGROUND:A novel oral agent that consists of trifluridine and tipiracil hydrochloride (TFTD) has been established as salvage-line treatment for metastatic colorectal cancer (mCRC). Adherence to TFTD is crucial to maintaining appropriate curative effects. This study sought to clarify adherence to TFTD and identify can...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000448717

    authors: Sugita K,Kawakami K,Yokokawa T,Sugisaki T,Takiguchi T,Aoyama T,Suzuki K,Suenaga M,Yamaguchi K,Inoue A,Machida Y,Yamaguchi T,Hama T

    更新日期:2016-01-01 00:00:00

  • Potential applications of high-dose megestrol acetate in breast cancer.

    abstract::Empiric clinical trials have revealed new mechanisms by which hormonal therapies may exert their antitumor effects. Initial studies using escalated doses of agents like toremifene and megestrol acetate have yielded interesting results, showing responses in hormone-receptor-negative patients and in patients progressing...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章

    doi:10.1159/000227121

    authors: Abrams JS,Gutheil J,Aisner J

    更新日期:1992-01-01 00:00:00

  • 5-fluorouracil/leucovorin combined with irinotecan and oxaliplatin (FOLFIRINOX) as second-line chemotherapy in patients with metastatic pancreatic adenocarcinoma.

    abstract:BACKGROUND:To evaluate the efficacy and toxicity of irinotecan and oxaliplatin plus 5-fluorouracil (FU) and leucovorin (FOLFIRINOX) as second-line therapy in metastatic pancreatic adenocarcinoma (MPA). PATIENTS AND METHODS:We retrospectively analyzed the medical records of 27 patients with MPA treated with FOLFIRINOX ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000329803

    authors: Assaf E,Verlinde-Carvalho M,Delbaldo C,Grenier J,Sellam Z,Pouessel D,Bouaita L,Baumgaertner I,Sobhani I,Tayar C,Paul M,Culine S

    更新日期:2011-01-01 00:00:00

  • Energy status in HeLa cells after treatment with an arresting anticancer drug.

    abstract::The energy status of HeLa cells arrested in the G2 phase of the cell cycle by the antineoplastic agent cis-acid was compared with that of normal G2-phase-synchronized cells. The results showed that treatment with the drug has significantly decreased the adenylate pool, adenylate energy charge and phosphorylation poten...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226444

    authors: Al-Awadi FM,Al-Bader AA

    更新日期:1987-01-01 00:00:00

  • Gemcitabine and cisplatin in refractory malignant lymphoma.

    abstract:OBJECTIVE:We performed a pilot study to evaluate the effect of the high-dose gemcitabine-cisplatin combination in a brief weekly regimen in the treatment of primary refractory diffuse large cell lymphoma with high or high-intermediate clinical risk. METHODS:Thirty patients refractory to first-line anthracycline-based ...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章

    doi:10.1159/000077995

    authors: Avilés A,Neri N,Huerta-Guzmán J,Fernández R

    更新日期:2004-01-01 00:00:00

  • Less Fibrotic Burden Differently Affects the Long-Term Outcomes of Hepatocellular Carcinoma after Curative Resection.

    abstract:BACKGROUND:The clinical features of hepatocellular carcinoma (HCC) differ in patients with and without cirrhosis. OBJECTIVE:We aimed to investigate the long-term outcomes of noncirrhotic HCC patients after curative resection. METHODS:We retrospectively examined 649 consecutive patients with HCC who underwent curative...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000477173

    authors: Lee HW,Choi GH,Kim DY,Park YN,Kim KS,Choi JS,Ahn SH,Han KH

    更新日期:2017-01-01 00:00:00

  • Loss of p16/CDKN2A protein in Epstein-Barr virus-associated gastric carcinoma.

    abstract::We examined the expression of p16, the CDKN2A gene product, in EBV-associated gastric carcinomas (EBV-GCs). EBV-GCs were identified by detecting EBV-encoded small RNA (EBER) using an in situ hybridization assay of paraffin-embedded tissue. Two non-EBV-GC cases for each EBV-GC case were selected, matched for age, sex, ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000080290

    authors: Koriyama C,Kitajima S,Nomoto M,Sueyoshi K,Itoh T,Eizuru Y,Yonezawa S,Akiba S

    更新日期:2004-01-01 00:00:00

  • Conversion of Lewis lung carcinoma into ascitic form.

    abstract::Lewis lung carcinoma (3LL), which has been most frequently used for various investigations of cancer, was converted to an ascitic form designated 3LL-SA. Ascites tumor cells showed a mixed population of single cells and about 10% islands which were made up of 2 to about 50 cells. Transplantability was 100%. The biolog...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226712

    authors: Sato T,Takusagawa K,Asoo N,Kumano N,Hasuike M,Konno K

    更新日期:1989-01-01 00:00:00

  • Serum Exosomal Gamma-Glutamyltransferase Activity Increased in Patients with Renal Cell Carcinoma with Advanced Clinicopathological Features.

    abstract:BACKGROUND:There has been no clinically useful diagnostic or prognostic biomarker for renal cell carcinoma (RCC). Serum γ-glutamyltransferase (GGT) activity has been reported to be a prognostic marker for several types of cancer including RCC. Exosomes or small extracellular vesicles present in body fluids have potenti...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000508688

    authors: Horie K,Kawakami K,Fujita Y,Matsuda Y,Arai T,Suzui N,Miyazaki T,Koie T,Mizutani K,Ito M

    更新日期:2020-01-01 00:00:00

  • A newly identified MAGE-3-derived, HLA-A24-restricted peptide is naturally processed and presented as a CTL epitope on MAGE-3-expressing gastrointestinal cancer cells.

    abstract:PURPOSE:In order to broaden the possibility for anti-MAGE-3 immune targeting, it is important to identify HLA-A24-restricted epitopes derived from MAGE-3, since HLA-A24 is one of the most common alleles in Japanese and Asian people. In the present study, we defined a new MAGE-3 derived, HLA-A24-binding peptide presente...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000091185

    authors: Miyagawa N,Kono K,Mimura K,Omata H,Sugai H,Fujii H

    更新日期:2006-01-01 00:00:00

  • Immunologic and immunohistochemical studies on chronic lymphocytic thyroiditis with or without thyroid lymphoma.

    abstract::The local immunologic phenomena in the thyroid gland of 16 patients with chronic lymphocytic thyroiditis (CLTH) were investigated; 5 of these cases were associated with thyroid non-Hodgkin's lymphomas (NHL). All patients were admitted because of struma, growing slowly in patients with CLTH alone and rapidly in those w...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226897

    authors: Aozasa K,Tajima K,Tominaga N,Katagiri S,Yonezawa T,Matsuzuka F,Kuma K,Sawada M

    更新日期:1991-01-01 00:00:00

  • Growth inhibition and modulation of cell markers of melanoma by S-allyl cysteine.

    abstract::A sulfur-containing amino acid compound, S-allyl cysteine (SAC), derived from garlic extract inhibited proliferation of nine human and murine melanoma cell line in a dose-dependent manner (1.2-10 mM) assessed by a [3H]thymidine incorporation assay. Three control human lymphoblastoid cell lines were not inhibited by SA...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227149

    authors: Takeyama H,Hoon DS,Saxton RE,Morton DL,Irie RF

    更新日期:1993-01-01 00:00:00

  • Development of cytotoxic cells during in vitro cultures of pleural effusion lymphocytes from patients with lung cancer.

    abstract::Culture-induced cytotoxic (CIC) activity developed in 7-day culture in the presence of fetal calf serum of pleural effusion lymphocytes from patients with lung cancer which initially showed markedly low or no natural killing (NK) activity against K562 cells. The development of CIC activity was proliferation-dependent....

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225637

    authors: Uchida A,Micksche M

    更新日期:1982-01-01 00:00:00

  • Different Toxicity of Cetuximab and Panitumumab in Metastatic Colorectal Cancer Treatment: A Systematic Review and Meta-Analysis.

    abstract:BACKGROUND:Over the last few years only one large randomized phase III study has tried to prospectively assess the safety of cetuximab and panitumumab in a head-to-head comparison. Despite the similar overall toxicity profile, cetuximab and panitumumab retain peculiar safety characteristics that deserve to be deeply in...

    journal_title:Oncology

    pub_type: 杂志文章,meta分析,评审

    doi:10.1159/000486338

    authors: Petrelli F,Ardito R,Ghidini A,Zaniboni A,Ghidini M,Barni S,Tomasello G

    更新日期:2018-01-01 00:00:00

  • Prognostic Factors in HER2-Positive Primary Breast Cancer Patients Treated Using Neoadjuvant Chemotherapy Plus Trastuzumab.

    abstract:BACKGROUND:It is unclear for whom new anti-human epidermal growth factor receptor 2 (anti-HER2) agents, such as pertuzumab and T-DM1, should be considered. We investigated prognostic factors before neoadjuvant chemotherapy (NAC) among HER2-positive invasive breast cancer patients and those after NAC among patients who ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000502910

    authors: Fujita N,Enomoto Y,Inakami K,Yanagisawa T,Iguchi C,Aono T,Nomura T,Yamamoto H,Kasugai T,Shiba E

    更新日期:2020-01-01 00:00:00

  • Cross-cultural application of the Korean version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire for patients with prostate cancer - EORTC QLQ-PR25.

    abstract:OBJECTIVE:We evaluated the psychometric properties of the Korean version of the European Organization for Research and Treatment of Cancer QLQ-PR25 when applied to Korean prostate cancer (PC) patients. METHODS:A total of 172 patients who underwent curative radical prostatectomy (RP) with or without adjuvant androgen d...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000355689

    authors: Park J,Shin DW,Yun SJ,Park SW,Jeon SS,Kwak C,Kwon TG,Kim HJ,Ahn H

    更新日期:2013-01-01 00:00:00

  • Antitumorous and immunomodulatory effects of the Viscum album L. preparation Isorel.

    abstract::There are numerous data on the immunostimulative and antitumorous activity of various Viscum album tissue extracts. Isorel (Novipharm, Austria) is one of these compounds. We found that in mice an increased number of plaque-forming cells to sheep red blood cells (SRBC) followed the injection of Isorel together with SRB...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227217

    authors: Jurin M,Zarković N,Hrzenjak M,Ilić Z

    更新日期:1993-11-01 00:00:00

  • Serum alphafetoprotein in bladder carcinoma.

    abstract::112 cases, of varying ages, which were diagnosed as having carcinoma of the bladder by cystoscopy and biopsy from the tumor, were investigated for the presence of alphafetoprotein (AFP) in the sera. 59 (52.6%) out of the total, showed positive results, and no false positive results occured. Radioimmunoassay was capabl...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225188

    authors: Alsabti EA

    更新日期:1977-01-01 00:00:00

  • Prognostic and therapeutic significance of carbohydrate antigen 19-9 as tumor marker in patients with pancreatic cancer.

    abstract::In pancreatic cancer (PC) accurate determination of treatment response by imaging often remains difficult. Various efforts have been undertaken to investigate new factors which may serve as more appropriate surrogate parameters of treatment efficacy. This review focuses on the role of carbohydrate antigen 19-9 (CA 19-...

    journal_title:Oncology

    pub_type: 杂志文章,评审

    doi:10.1159/000094888

    authors: Boeck S,Stieber P,Holdenrieder S,Wilkowski R,Heinemann V

    更新日期:2006-01-01 00:00:00

  • Platelet-derived growth factor receptor beta serum concentrations during first-line therapy in ovarian cancer.

    abstract:OBJECTIVES:Angiogenesis plays an important role in ovarian cancer. The interaction of platelet-derived growth factor receptor-beta (PDGFR-β) with vascular endothelial growth factor (VEGF) in the process of angiogenesis may represent an essential feature in the progression of the disease. METHODS:Patients with epitheli...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000351032

    authors: Mathey S,Graeser MK,Zu Eulenburg C,Woelber L,Trillsch F,Jaenicke F,Müller V,Milde-Langosch K,Mahner S

    更新日期:2013-01-01 00:00:00

  • In vitro and in vivo growth inhibition of SC-M1 gastric cancer cells by retinoic acid.

    abstract::Retinoids are differentiating agents that have been used successfully for the treatment of acute promyelocytic leukemia. When combined with interferons, they are active in preventing second malignancies in patients with head and neck cancer. Our previous studies have demonstrated cytostatic effects of alltrans-retinoi...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227583

    authors: Jiang SY,Shyu RY,Chen HY,Lee MM,Wu KL,Yeh MY

    更新日期:1996-07-01 00:00:00

  • Rechallenge with platinum plus fluoropyrimidine +/- epirubicin in patients with oesophagogastric cancer.

    abstract:PURPOSE:There is no standard second-line therapy for patients with oesophagogastric cancer who progress following first-line chemotherapy for advanced disease or relapse following radical multi-modality therapy. The aim of this retrospective study was to evaluate survival following rechallenge with platinum plus fluoro...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000322114

    authors: Okines AF,Asghar U,Cunningham D,Ashley S,Ashton J,Jackson K,Hawkes E,Chau I

    更新日期:2010-01-01 00:00:00

  • Phase II study of gemcitabine and cisplatin in patients with advanced or metastatic bladder cancer: long-term follow-up of a 3-week regimen.

    abstract:BACKGROUND:Bladder cancer is the fifth most common cancer among men and the seventh among women. At diagnosis, at least 25% of bladder cancer tumors are locally or systemically advanced. Systemic chemotherapy is the only current modality for advanced or metastatic transitional cell carcinoma of the bladder. Recently, a...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000089993

    authors: Adamo V,Magno C,Spitaleri G,Garipoli C,Maisano C,Alafaci E,Adamo B,Rossello R,Scandurra G,Scimone A

    更新日期:2005-01-01 00:00:00

  • Implications of flow cytometry in preoperative detection of biologic variables of gastric cancer and malignant condition of gastric remnant cells obtained by endoscopic biopsy.

    abstract::Flow cytometric (FCM) DNA studies were performed on cell suspensions obtained by endoscopic biopsy in 73 patients with gastric cancer and in 61 patients with gastric remnant. In cancer, DNA aneuploidies were detected in 49 tumors (67.1%), including 51.7% (15/29) of early gastric cancers and 77.3% (34/44) of advanced g...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227389

    authors: Kimura H,Kanno M,Takamura H,Arakawa H,Maeda K,Uogishi M,Sodani H,Kawashima T

    更新日期:1994-11-01 00:00:00

  • High-dose chemotherapy and autologous hematopoietic stem cell transplantation: the lymphoma experience and its potential relevance to solid tumors.

    abstract::Lymphomas, which are frequently subdivided into Hodgkin's disease and non-Hodgkin's lymphoma, represent one of the more curable cancers that present as a solid tumor. Unfortunately, most patients cannot be cured with conventional chemotherapy, therefore new techniques have been developed including high-dose chemothera...

    journal_title:Oncology

    pub_type: 杂志文章,评审

    doi:10.1159/000012100

    authors: Armitage JO

    更新日期:2000-04-01 00:00:00

  • Testicular lymphoma: organ-specific treatment did not improve outcome.

    abstract:OBJECTIVES:To assess whether the use of an organ-specific treatment could improve event-free survival (EFS) and overall survival as endpoints in testicular lymphoma in the early stage: IE and IIE. METHODS:Thirty-four patients were selected to be treated with orchiectomy following six cycles of anthracycline-based comb...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章

    doi:10.1159/000081319

    authors: Avilés A,Neri N,Huerta-Guzmán J,Pérez F,Fernández R

    更新日期:2004-01-01 00:00:00

  • Unexpectedly low incorporation of isotopic acetate into lipids of Ehrlich ascites tumor cells cultured in lipid-poor medium.

    abstract::The present communication reports data on the lipid biosynthesis of Ehrlich ascites tumor cells grown in culture media supplemented with modified sera. Whereas the metabolisms of [14C]pyruvate and [14C]mevalonate are identical in all media tested, the incorporation of [14C] acetate is higher in medium with dialyzed se...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225321

    authors: Löffler M,Schneider F

    更新日期:1979-01-01 00:00:00

  • Differences in the Efficacies of Pazopanib and Gemcitabine/Docetaxel as Second-Line Treatments for Metastatic Soft Tissue Sarcoma.

    abstract:BACKGROUND:We retrospectively investigated the treatment outcomes of second-line treatment with pazopanib or gemcitabine/docetaxel in patients with advanced soft tissue sarcoma (STS). METHODS:Ninety-one patients who were treated with pazopanib or gemcitabine/docetaxel for advanced STS between 1995 and 2015 were analyz...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000492597

    authors: Kim JH,Park HS,Heo SJ,Kim SK,Han JW,Shin KH,Kim SH,Hur H,Kim KS,Choi YD,Kim S,Lee YH,Suh JS,Ahn JB,Chung HC,Noh SH,Rha SY,Kim HS

    更新日期:2019-01-01 00:00:00